HFS
TXG icon

Hantz Financial Services’s 10x Genomics TXG Stock Holding History

Hantz Financial Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
23
– – ﹤0.01% 2609
2025
Q4 		$0 Hold
23
– – ﹤0.01% 2535
2025
Q3 		$0 Hold
23
– – ﹤0.01% 2450
2025
Q2 		$0 Buy
+23
New +$210 ﹤0.01% 2302

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hantz Financial Services's TXG Position: Q1 2026 in Review

Hantz Financial Services held its 10x Genomics (TXG) position steady in Q1 2026 at 23 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Hantz Financial Services first reported a position in TXG in Q2 2025 and has held it in 4 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Hantz Financial Services held 23 shares of 10x Genomics worth $0 as of Q1 2026.
  • Hantz Financial Services left its 10x Genomics share count unchanged in Q1 2026.
  • 10x Genomics made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2609 holding.
  • Hantz Financial Services first reported a position in 10x Genomics in Q2 2025 and has held it in 4 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.